CVS-1123 oral thrombin inhibitor: Began Phase Ia dose escalation testing in healthy men in the U.K., to assess safety, pharmacokinetics and side effects. CVS-11

Corvas International Inc. (CVAS), San Diego Product: CVS-1123 oral thrombin inhibitor Indication: Thrombotic diseases such as venous thrombosis, unstable angina, and atrial fibrillation Status: Began ...